MHRA resumes international Inspections
Right at the start of the Covid 19 pandemic, in March 2020, the UK MHRA published a blog post on the progress of on-site inspections. These were limited to inspections related to the UK government's COVID-19 response or other potential serious public health risks. As the pandemic and developments unfolded, more on-site inspections were then carried out again in the UK. However, there was not really a return to international inspections.
Meanwhile, international travel has become easier to organise again. A pilot programme has started in April 2022 to look at a possible return to international GMP on-site inspections. In a MHRA Inspecctorate Blog entitled "Return to International GMP Inspections" now published, it is announced that the pilot project was successful and the MHRA is resuming the programme of international GMP on-site inspections, albeit with restrictions. A risk-based approach will be taken.
Validity of GMP certificates
During the pandemic, a "pragmatic approach" was taken to the validity of GMP certificates. These were first extended to the end of 2021 and then to the end of 2022. The blog now also states that GMP certificates issued by the MHRA will be extended again until the end of 2023.
Related GMP News
24.07.2024FDA Warning Letter to a Manufacturer of an Athlete Muscle Maintenance Creme
24.07.2024FDA describes detailed CAPA Procedure in Warning Letter
17.07.2024Congressional Scrutiny on FDA's Foreign Inspection Program puts Pressure on Agency
19.06.2024More FDA Inspections again - also in the EU?
12.06.2024GMP Problems with critical Medicinal Products - what now?
15.05.2024Lack of Quality Oversight: EU Non-Compliance Report issued to Omeprazole Manufacturer